A randomized, blind comparison of remifentanil and alfentanil during anesthesia for outpatient surgery

Anesthesia and Analgesia

Volumn 85, Issue 5, 1997, Pages 1014-1019

  Cartwright, D Paul ^a   Kvalsvik, Odvaar ^b   Cassuto, Jean ^c   Jansen, Jan Peter ^d   Wall, Carmel ^e   Remy, Bernadette ^f   Knape, Johanus Th A ^g   Noronha, Drusilla ^h   Upadhyaya, Bharat K ⁱ  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^b Regionsykehuset T   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d Pain Centre   (Germany)

^e University College Cork and INFANT Centre   (Ireland)

^f CHU SART TILMAN   (Belgium)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h Medical Statistics Department   (United Kingdom)

ⁱ GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; REMIFENTANIL;

ADULT; AMBULATORY SURGERY; ANALGESIC ACTIVITY; ANESTHETIC RECOVERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EXTUBATION; FEMALE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SHIVERING;

ADOLESCENT; ADULT; AGED; ALFENTANIL; AMBULATORY SURGICAL PROCEDURES; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERIDINES;

EID: 0030783301     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199711000-00011     Document Type: Article

References (16)

1. Glass PSA, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993;77:1031-40.
2. Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-41.
3. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903.
4. Kapila A, Muir KT, Hermann DJ, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995;83:968-75.
5. James MK. Remifentanil and anaesthesia for the future. Exp Opin Invest Drugs 1994;3:331-40.
6. Monk TG, Batenhorst RL, Folger WH, et al. A comparison of remifentanil and alfentanil during nitrous-narcotic anesthesia. Anesth Analg 1994;78:S293.
7. Kallar SK, Hurt TW, Wetcher BV, et al. A single blind, comparative study of the safety and efficacy of remifentanil and alfentanil for outpatient anesthesia. Anesthesiology 1994;81(3A):A32.
8. Aldrete JA, Kronlik D. A post-anaesthetic recovery score. Anesth Analg 1970;49:924-33.
9. Trieger N, Newman MG, Miller JG. An objective measure of recovery. Anesth Prog 1969;16:4-7.
10. Kortilla K, Nuotto E, Lichtor L, et al. Recovery and psychomotor effects after brief anesthesia with propofol and thiopental. Anesth Analg 1989;68:S151.
11. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984:91-110.
12. Pearce KE. Biopharmaceutical statistics for drug development. New York: Marcel Decker Inc, 1988:403-53.
13. Fleiss JL. The designs and analysis of clinical experiments. New York: John Wiley and Sons, 1986:186-207.
14. Schuttler J, Albrecht S, Breivik H, et al. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997;52:307-17.
15. Kapila A, Lang E, Glass P, et al. MAC reduction of isoflurane by remifentanil. Anesthesiology 1994;81:A378.
16. Barash PG, Cullen BF, Stoelting RK. Handbook of clinical anesthesia. Philadelphia: JB Lippincott, 1993:166-70.